Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
A patient comes in on semaglutide for type 2 diabetes
The phase 3 TRIUMPH-4 trial extended to 68 weeks and showed continued weight loss throughout, suggesting that longer maintenance periods produce better outcomes
Were reviewing future options, but currently prescription medications are paid by the patient
Weve seen a 65% increase in patients seeking advanced pharmacological support at our centers since the widespread adoption of GLP-1 therapies began in early 2023
US$ 29.95
US$ 24.97
US$ 27.32
